Home› Stocks› MRNA
Not investment advice. AI-generated analysis for educational purposes only. All trading involves risk of loss. Past performance does not guarantee future results. Full disclaimer

MRNA

STRONG BUY

Health Care · S&P 500

Last updated: September 11, 2026 at 15:56 UTC

TRADEWISE AI SCORE

100

out of 100 — 6-factor composite

6-Factor Analysis

Based on Jegadeesh & Titman (1993) momentum and Barroso & Santa-Clara (2015) volatility targeting.

FactorValueStrengthDetail
Composite Momentum +264.7%
Multi-timeframe weighted (1/3/6/12mo)
Relative Strength vs SPY +180.7%
3-month outperformance vs S&P 500
20-Day Momentum +126.7%
Short-term price momentum
RSI-14 35.6
Relative Strength Index
Volatility 626.1%
20-day annualised: 626.1%

AI Debate Summary

4 AI agents (Research, Risk, Macro, Devil's Advocate) debated MRNA.

AI Debate from September 11, 2026 — data may be outdated. Get fresh analysis
ATLAS HOLD 42.0%

VOTE: HOLD CONFIDENCE: 42 --- ## ASSESSMENT: NEUTRAL MRNA presents a high-conviction *momentum setup* embedded in a fundamentally **broken capital structure** that disqualifies conviction above 50%.

Read full analysis →

SENTINEL HOLD 35.0%

VOTE: HOLD CONFIDENCE: 35 --- **ASSESSMENT: NEUTRAL — GENUINE CONVICTION DEFICIT** This is NOT a volatility-phobia HOLD. I can read the regime (TRENDING_BULL, all indices +5-8% above 200-SMA, VIX 16

Read full analysis →

HORIZON HOLD 52.0%

VOTE: HOLD CONFIDENCE: 52 --- **1. MACRO-STOCK TRANSMISSION** Healthcare biotech (MRNA's sector) is generally *rate-insensitive* relative to high-beta growth. Rising or stable rates do not directly

Read full analysis →

CONTRARIAN HOLD 38.0%

VOTE: HOLD CONFIDENCE: 38 ADVERSARIAL CLEARANCE: PASS --- ## 1. STRONGEST BULL CASE MRNA has a **perfect momentum score (100/100)** and **+264.7% composite weighted momentum** across 1mo/3mo/6mo/12mo

Read full analysis →

CONSENSUS VETO_APPROVED — 42% agreement

Full debate reasoning available on Pro tier.

Market Regime Context

CURRENT REGIME CHOPPY (Day 7)

TradeWise monitors 5 market states (CALM → CRISIS) using VIX, breadth, and tail risk signals. In CHOPPY regime, the system adjusts position limits, trailing stops, and cash reserves automatically. Learn more about regime detection.

Get real-time AI alerts for MRNA

4 AI agents debate every trade. 6-factor scoring. Regime-adaptive risk management. 14-day free trial, no credit card.

Start Free Trial →

Health Care Sector Peers

LLYUNHJNJABBVMRKTMOABTDHRPFEAMGN

View all Health Care stocks →

Compare

MRNA vs LLYMRNA vs UNHMRNA vs JNJMRNA vs ABBVMRNA vs MRK

Frequently Asked Questions

Is MRNA a buy right now?

Based on TradeWise's 6-factor AI model, MRNA currently scores 100/100, indicating a STRONG BUY signal. This combines momentum, volume, trend structure, volatility, sector relative strength, and drawdown analysis. The current market regime is CHOPPY. Updated September 11, 2026 at 15:56 UTC.

What is the TradeWise AI score for MRNA?

MRNA has a TradeWise AI score of 100/100. Scores above 80 indicate STRONG BUY, 65-80 BUY, 45-65 HOLD, 30-45 WEAK, below 30 AVOID. Scores are updated daily based on the V56 momentum engine scanning all S&P 500 stocks.

How does MRNA compare to LLY?

Compare MRNA against sector peers using our head-to-head AI comparison tool. Each comparison shows 6-factor score breakdown, AI debate excerpts, and regime-adjusted analysis. See comparison →

Disclaimer: TradeWise provides AI-generated analysis for educational purposes only. This is not financial advice. Past performance does not guarantee future results. All investing involves risk of loss. Backtested results are hypothetical. Consult a qualified financial adviser before making investment decisions. Scores generated by the V56 momentum engine based on Jegadeesh & Titman (1993) momentum research and Barroso & Santa-Clara (2015) volatility targeting.